Combination of noninvasive brain stimulation with pharmacotherapy

References

• Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord.8(2), 203–204 (2006).
   PubMed Web of Science ®Google Scholar
• Boggio P, Rigonatti S, Ribeiro R et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int. J. Neuropsychopharmacol.11(2), 249–254 (2008).
   PubMed Web of Science ®Google Scholar
• Loo CK, Sachdev P, Martin D et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int. J. Neuropsychopharmacol.12, 1–9 (2009).
   Google Scholar
• Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress. Anxiety26(3), 279–288 (2009).
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Fraguas R, Fregni F. Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability. Ther. Clin. Risk Manag.5, 897–910 (2009).
   PubMedGoogle Scholar
• Brunoni AR, Fregni F. Clinical trial design in noninvasive brain stimulation psychiatric research. Int. J. Methods Psychiatr. Res. (2010) (In press).
   Google Scholar
• Fregni F, Santos CM, Myczkowski ML et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry75(8), 1171–1174 (2004).
   PubMed Web of Science ®Google Scholar
• Rossini D, Magri L, Lucca A, Giordani S, Smeraldi E, Zanardi R. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. J. Clin. Psychiatry.66(12), 1569–1575 (2005).
   PubMed Web of Science ®Google Scholar
• Rumi DO, Gattaz WF, Rigonatti SP et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol. Psychiatry57(2), 162–166 (2005).
   PubMed Web of Science ®Google Scholar
• Herwig U, Fallgatter AJ, Hoppner J et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br. J. Psychiatry191, 441–448 (2007).
   PubMed Web of Science ®Google Scholar
• Bretlau LG, Lunde M, Lindberg L, Unden M, Dissing S, Bech P. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Pharmacopsychiatry41(2), 41–47 (2008).
   PubMed Web of Science ®Google Scholar
• Bares M, Kopecek M, Novak T et al. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. J. Affect Disord.118(1–3), 94–100 (2009).
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Lopes M, Kaptchuk TJ, Fregni F. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis. PLoS One4(3), e4824 (2009).
   PubMed Web of Science ®Google Scholar
• Fregni F, Marcolin MA, Myczkowski M et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int. J. Neuropsychopharmacol.9(6), 641–654 (2006).
   PubMed Web of Science ®Google Scholar
• Lisanby SH, Husain MM, Rosenquist PB et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology34(2), 522–534 (2009).
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry163(11), 1905–1917 (2006).
   PubMed Web of Science ®Google Scholar
• Gelenberg AJ, Thase ME, Meyer RE et al. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. J. Clin. Psychiatry.69(10), 1513–1528 (2008).
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Teng CT, Correa C et al. Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting. Arq. Neuropsiquiatr.68(3), 433–451 (2010).
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet373(9665), 746–758 (2009).
   PubMed Web of Science ®Google Scholar
• Rigonatti SP, Boggio PS, Myczkowski ML et al. Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur. Psychiatry23(1), 74–76 (2008).
   PubMed Web of Science ®Google Scholar
• Fergusson D, Glass KC, Waring D, Shapiro S. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ328(7437), 432 (2004).
   PubMed Web of Science ®Google Scholar
• Kaptchuk TJ, Stason WB, Davis RB et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ332(7538), 391–397 (2006).
   PubMed Web of Science ®Google Scholar
• Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet375(9715), 686–695 (2010).
   PubMed Web of Science ®Google Scholar
• Sinyor M, Levitt AJ, Cheung AH et al. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J. Clin. Psychiatry.71(3), 270–279 (2010).
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Tadini L, Fregni F. Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology. PLoS One5(3), e9479 (2010).
   PubMed Web of Science ®Google Scholar
• Freedman B. Equipoise and the ethics of clinical research. N. Engl. J. Med.317(3), 141–145 (1987).
   PubMed Web of Science ®Google Scholar
• Kim SY. Benefits and burdens of placebos in psychiatric research. Psychopharmacology (Berl.)171(1), 13–18 (2003).
   PubMed Web of Science ®Google Scholar
• Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied Linear Statistical Models. McGraw-Hill/Irwin, IL, USA (1996).
   Google Scholar
• Schutter D. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol. Med.39(1), 65–75 (2009).
   PubMed Web of Science ®Google Scholar
• Hidalgo R, Tupler L, Davidson J. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J. Psychopharmacol.21(8), 864–872 (2007).
   PubMed Web of Science ®Google Scholar
• Ottenbacher KJ, Ottenbacher HR, Tooth L, Ostir GV. A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions. J. Clin. Epidemiol.57(11), 1147–1152 (2004).
   PubMed Web of Science ®Google Scholar
• Bech P. Rating scales for mood disorders: applicability, consistency and construct validity. Acta Psychiatr. Scand. Suppl.345, 45–55 (1988).
   PubMedGoogle Scholar